Recap: Phibro Animal Health Q3 Earnings

Phibro Animal Health (NASDAQ:PAHC) reported its Q3 earnings results on Wednesday, May 3, 2023 at 04:30 PM. Here’s…

Phibro Animal Health (NASDAQ:PAHC) reported its Q3 earnings results on Wednesday, May 3, 2023 at 04:30 PM.

Here’s what investors need to know about the announcement.

Earnings

Phibro Animal Health missed estimated earnings by 12.12%, reporting an EPS of $0.29 versus an estimate of $0.33.

Revenue was up $6.10 million from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.04 which was followed by a 0.0% increase in the share price the next day.

Here’s a look at Phibro Animal Health’s past performance:

Quarter Q2 2023 Q1 2023 Q4 2022 Q3 2022
EPS Estimate 0.30 0.26 0.38 0.35
EPS Actual 0.34 0.21 0.36 0.33
Revenue Estimate 241.28M 227.54M 246.02M 226.26M
Revenue Actual 244.60M 232.50M 255.30M 239.60M

To track all earnings releases for Phibro Animal Health visit their earnings calendar here.

This article was generated by Benzinga’s automated content engine and reviewed by an editor.

Total
0
Shares
Related Posts
Read More

Mytheresa Announces Preliminary Q3 GMV In The Range Of €245 Million To €255 Million; Net Sales In The Range Of €230 Million To €235 Million; Sees FY24 GMV And Net Sales Growth In The Range Of 8%-13%

MYT Netherlands Parent B.V. (NYSE:MYTE) ("Mytheresa" or the "Company"), today announced preliminary unaudited financial results for the third quarter ended March 31, 2024, and confirmed the guidance for the full fiscal

MYTE